| UHC UMR Medical and Drug | Ablative Treatment for Spinal Pain – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Breast Imaging for Screening and Diagnosing Cancer – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Cimzia® (Certolizumab Pegol) – Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Computer-Assisted Surgical Navigation for Musculoskeletal Procedures – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Deep Brain and Cortical Stimulation – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Durable Medical Equipment, Orthotics, Medical Supplies, and Repairs/Replacements – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Infliximab (Avsola®, Inflectra®, Remicade®, & Renflexis®) - Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Intravenous Iron Replacement Therapy (Feraheme®, Injectafer®, & Monoferric®) - Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Kisunla™ (Donanemab-Azbt) – Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Manipulation Under Anesthesia – Commercial and Individual Exchange Medical Policy | 2026-02-01 |